Cardiology fellow @semmelweishu | Alumni research fellow @MassGeneral @CIRC_MGH | #CVImaging & #Cardiooncology
Budapest
Joined February 2012
- Tweets199
- Following905
- Followers431
- Likes1.4K
Pinned Tweet
Engaging correspondence regarding our recent paper in @CircAHA on ICI and ⬆️🧡⚡️ events| bit.ly/3xQVGr4 |Our response: bit.ly/2T5hRv5 with @TomasNeilan @th_mayrhofer|Video ⬇️for catching up #CardioOnc #ImmunoOnc @CIRC_MGH @semmelweishu
Zsofia D. Drobni, MD, PhD retweeted
Which Cardiac Troponin do You use in a patient with suspected ICI Myocarditis? Great to share @InovaHealth approach in #JACCCardioOnc @JACCJournals @ChrisDefilippi @RaymondWadlowMD @InovaSchar @ISHVnews sciencedirect.com/science/ar…
Zsofia D. Drobni, MD, PhD retweeted
Upgrade to cardiac resynchronisation therapy benefits #HeartFailure patients with pacing bit.ly/3quHgPG
#ESCCongress @DrMerkely
Zsofia D. Drobni, MD, PhD retweeted
Among study participants with lymphoma who were being treated with anthracyclines, prophylactic use of atorvastatin over 12 months was associated with a lower rate of cardiac systolic dysfunction. ja.ma/3QtDb8M
Zsofia D. Drobni, MD, PhD retweeted
Dr. Scott David Solomon, the world-renowned cardiologist of Harvard Medical School received the university’s most prestigious international scientific recognition, the Semmelweis Budapest Award. Heartfelt congratulations to Professor Solomon!
Read more:
semmelweis.hu/english/2023/0…
Zsofia D. Drobni, MD, PhD retweeted
New #JITC article: Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer bit.ly/3JU7gKE @zsofidrobni @TomasNeilan
Zsofia D. Drobni, MD, PhD retweeted
Should post STEMI PCI pathway include routine #FFRCT for assessing flow impairment of non culprit lesions? 🫀Thought provoking #XPECTMI study suggests #YesCCT at index event can predict future invasive FFR‼️
Fantastic work by @semmelweishu researchers! Congrats!
Zsofia D. Drobni, MD, PhD retweeted
Congrats @husam247 and @dineshpmcc1. Definitely enough now to think of a RCT. If only the SGLT2i companies were interested…
We are excited to share our latest open-access #cardiooncology paper examining the enticing idea that SGLT2I use during anthracycline chemotherapy with the risk of #heartfailure by reducing the risk of #cardiotoxicity
sciencedirect.com/science/ar…
Zsofia D. Drobni, MD, PhD retweeted
Fabulous work by @zsofidrobni from @semmelweishu and @CIRC_MGH on atherosclerosis with immune therapy. Thank you Dr. Ky for your leadership and your interest in this work. #ACC2023 #cardioonc
Zsofia D. Drobni, MD, PhD retweeted
Grateful for this amazing #CardioOnc team 🫀💉💊 with @zsofidrobni led by the @TomasNeilan @CIRC_MGH @MGHHeartHealth.
Zsofia D. Drobni, MD, PhD retweeted
Ibolya is a fantastic medical educator and recipient of @EinsteinMed Davidoff Society Teaching star award. 🌟
She is a team player, and an incredible source of support to her co-residents and interns. Thank you Ibi!! #JacobiStrong #MedTwitter #IMG #CardioTwitter
Zsofia D. Drobni, MD, PhD retweeted
From @jaccjournals, over 30% of cancer patients are eligible for an ICI. A review on the potential for ICI related atherosclerosis - JACC: CardioOncology led by the amazing @GiselleSA_MDPhD from @MGHHeartHealth and @MGHCVFellows rb.gy/sgywti
Zsofia D. Drobni, MD, PhD retweeted
Sodium-glucose cotransporter-2 inhibitors and heart failure and mortality in patients with cancer heart.bmj.com/content/early/…
In a large mostly non-anthracycline cancer population, SGLT2i use was associated with lower incident HF and prolonged overall survival
Really privileged to contribute to this work led by Dr. Trost and many other mentors @hopkinsheart
Cardiac imaging is a hugely exciting place to be right now, stay tuned!
jacc.org/doi/10.1016/j.jacad…
Zsofia D. Drobni, MD, PhD retweeted
Be sure to read the latest ESMO Clinical Practice Guideline @Annals_Oncology for multi-disciplinary guidance on toxicities from cancer immunotherapy. @myESMO
annalsofoncology.org/article…
Great summary of the #DISCHARGE trial results by @ProfDewey at the Hungarian CV Imaging Meeting! 💁🏻♀️ Stay tuned for the results from the next analysis! 👱♂️🫀👩🦳 @PalMaurovich @team_dewey @semmelweishu #CardiacCT #chestpain
Neilan lab reunion at #GCOS2022 @CIRC_MGH @TomasNeilan @AZafar_MD @GiselleSA_MDPhD @CardioOnco_JHE Thank you @ICOSociety @CCardiacON, fantastic meeting! 🇨🇦 #ATRIUMTRIAL
Zsofia D. Drobni, MD, PhD retweeted
Excellent discussion case on 5-FU toxicity/capecitabine - by Dr Nohria, @b_dhesy - the case is not clear yet.. tune in to hear till the end of pre-conference of #GCOS22 @dineshpmcc1
Drs. Anju Nohria and Bindi Dhesy-Thind sharing their expertise about fluorouracil associated cardiotoxicity at the #gcos2022 pre-meeting #cardiooncology
Zsofia D. Drobni, MD, PhD retweeted
#GCOS2022 Pre-conference starting today - 1 PM EST. Listen to @JLiu_MSKCardOnc and @TeresaLpezFdez1 discuss 3D + strain acquisition and analysis - tips and tricks. Then highly interactive case discussions with experts! @ICOSociety @CCardiacON @trogersresearch @PMunkCardiacCtr
